Partner Content Partner Content Spotlight sessions at the upcoming Lyophilization USA Confer... Lyophilization USA Conference
Partner Content Partner Content Achieving Controlled Nucleation During Aseptic Lyophilizatio... 4th Annual Lyophilization USA Conference
Partner Content Partner Content SMi’s exclusive speaker interview with Abon Pharmaceuticals,... SMi Reports: An exclusive interview with Dr.
Partner Content Partner Content Optimization of Lyophilization and alternatives to conventio... SMi Group reports: Alina Alexeenko of Purdue University presenting LyoHub's overview and strategies for the future of lyophilization and alternatives to conventional methods
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
